Eldoret: Moi Teaching and Referral Hospital (MTRH) has announced a strengthened partnership with Pfizer, a leading global pharmaceutical company, to improve cancer care and foster medical innovation. MTRH Chief Executive Officer Dr. Philip Kirwa emphasized the importance of global partnerships in transforming patient healthcare, particularly in specialized areas such as cancer treatment.
According to Kenya News Agency, Dr. Kirwa highlighted that collaborations with global pharmaceutical companies are crucial in supporting efforts to enhance patient care. He noted that the partnership would create new opportunities for collaboration, which would have a direct impact on the lives of patients, many of whom travel from across the region to access MTRH services.
During a visit from Dr. Albert Bourla, Pfizer’s Chairman and Chief Executive Officer, Dr. Kirwa discussed the potential for joint initiatives in medical research, innovation, and capacity building. These collaborations are expected to accelerate the adoption of advanced healthcare technologies and essential medicines, reinforcing a shared vision between the public health sector and pharmaceutical companies to advance cancer care and medical research.
MTRH, one of Kenya’s largest referral hospitals, continues to establish itself as a regional hub for specialized care, with a focus on oncology and pathology services. Dr. Kirwa reaffirmed the hospital’s commitment to forming strategic alliances that enhance its ability to deliver world-class healthcare.
Dr. Bourla expressed that the visit marks a significant step in deepening Pfizer’s partnership with Kenya’s healthcare sector. He reiterated the company’s dedication to advancing healthcare across Africa and emphasized the importance of public-private partnerships in addressing pressing health challenges.
‘Moi Teaching and Referral Hospital is a beacon of hope for millions of people in this region,’ Dr. Bourla remarked. He reiterated Pfizer’s commitment to working alongside Kenyan healthcare leaders to expand access to life-saving treatments and foster medical innovation, ensuring that no patient is left behind in the fight against cancer and other serious illnesses.
